# Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

> **NCT06872372** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Lahore General Hospital** · enrollment: 62 (actual)

## Conditions studied

- Acute Liver Failure
- Drug-Induced Liver Injury

## Interventions

- **DRUG:** N-Acetylcysteine (NAC) Treatment
- **OTHER:** Standard supportive care

## Key facts

- **NCT ID:** NCT06872372
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-07-15
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06872372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06872372, "Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06872372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*